Tarsus Pharmaceuticals (TARS) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Tarsus Pharmaceuticals (TARS) over the last 6 years, with Q3 2025 value amounting to -$2.1 million.
- Tarsus Pharmaceuticals' Other Gross PP&E Adjustments fell 18837.41% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 18837.41%. This contributed to the annual value of -$1.0 million for FY2024, which is 6437.78% up from last year.
- Latest data reveals that Tarsus Pharmaceuticals reported Other Gross PP&E Adjustments of -$2.1 million as of Q3 2025, which was down 18837.41% from $4.9 million recorded in Q2 2025.
- Tarsus Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $4.9 million for Q2 2025, and its period low was -$2.9 million during Q4 2023.
- In the last 5 years, Tarsus Pharmaceuticals' Other Gross PP&E Adjustments had a median value of $251000.0 in 2022 and averaged $469526.3.
- In the last 5 years, Tarsus Pharmaceuticals' Other Gross PP&E Adjustments tumbled by 122688.17% in 2021 and then skyrocketed by 69237.29% in 2024.
- Quarter analysis of 5 years shows Tarsus Pharmaceuticals' Other Gross PP&E Adjustments stood at -$1.2 million in 2021, then rose by 3.48% to -$1.2 million in 2022, then tumbled by 140.89% to -$2.9 million in 2023, then skyrocketed by 64.38% to -$1.0 million in 2024, then tumbled by 105.28% to -$2.1 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$2.1 million for Q3 2025, versus $4.9 million for Q2 2025 and $3.9 million for Q1 2025.